These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 7643714)

  • 21. Pharmacology and structure-activity relationships for KATP modulators: tissue-selective KATP openers.
    Atwal KS
    J Cardiovasc Pharmacol; 1994; 24 Suppl 4():S12-7. PubMed ID: 7898103
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacological interaction experiments differentiate between glibenclamide-sensitive K+ channels and cyclic GMP as components of vasodilation by nicorandil.
    Holzmann S; Kukovetz WR; Braida C; Pöch G
    Eur J Pharmacol; 1992 Apr; 215(1):1-7. PubMed ID: 1325362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of pulmonary and systemic vascular responses to cromakalim, an activator of K+ATP channels.
    Minkes RK; Kvamme P; Higuera TR; Nossaman BD; Kadowitz PJ
    Am J Physiol; 1991 Mar; 260(3 Pt 2):H957-66. PubMed ID: 1825747
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the in vitro effects of K+ channel modulators on detrusor and portal vein strips from guinea pigs.
    Zografos P; Li JH; Kau ST
    Pharmacology; 1992; 45(4):216-30. PubMed ID: 1438528
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interaction of potassium channel openers and blockers in canine atrial muscle.
    Yanagisawa T; Hashimoto H; Taira N
    Br J Pharmacol; 1989 Jul; 97(3):753-62. PubMed ID: 2527073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetics of bupivacaine after nicorandil treatment in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    J Pharm Pharmacol; 1996 Jul; 48(7):749-52. PubMed ID: 8866342
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Potential role of ATP-sensitive K+ channels in ischemia- and reperfusion-induced arrhythmias].
    Nakaya H
    Kokyu To Junkan; 1993 Jun; 41(6):512-20. PubMed ID: 8337509
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of diazoxide, cromakalim and pinacidil on adrenergic neurotransmission and 86Rb+ efflux in rat brain cortical slices.
    Takata Y; Shimada F; Kato H
    J Pharmacol Exp Ther; 1992 Dec; 263(3):1293-301. PubMed ID: 1469635
    [TBL] [Abstract][Full Text] [Related]  

  • 29. K+ channel openers delay intestinal transit and have antidiarrheal activity.
    Poggioli R; Benelli A; Arletti R; Cavazzuti E; Bertolini A
    Eur J Pharmacol; 1995 Dec; 287(2):207-9. PubMed ID: 8749038
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific but differential antagonism by glibenclamide of the vasodepressor effects of cromakalim and nicorandil in spinally-anaesthetized dogs.
    Yamada H; Yoneyama F; Satoh K; Taira N
    Br J Pharmacol; 1990 Jul; 100(3):413-6. PubMed ID: 2143956
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lack of effect of potassium channel openers on ATP-modulated potassium channels recorded from rat ventromedial hypothalamic neurones.
    Sellers AJ; Boden PR; Ashford ML
    Br J Pharmacol; 1992 Dec; 107(4):1068-74. PubMed ID: 1467829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differential effects of endothelin-1 on the vasorelaxant properties of benzopyran and non-benzopyran potassium channel openers.
    Lawson K; Barras M; Zazzi-Sudriez E; Martin DJ; Armstrong JM; Hicks PE
    Br J Pharmacol; 1992 Sep; 107(1):58-65. PubMed ID: 1422579
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of vasorelaxant responses to potassium channel openers by basal nitric oxide in the rat isolated superior mesenteric arterial bed.
    McCulloch AI; Randall MD
    Br J Pharmacol; 1996 Mar; 117(5):859-66. PubMed ID: 8851502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of K+ channel agonists cromakalim and pinacidil on rat basilar artery smooth muscle cells are mediated by Ca(++)-activated K+ channels.
    Stockbridge N; Zhang H; Weir B
    Biochem Biophys Res Commun; 1991 Nov; 181(1):172-8. PubMed ID: 1958186
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anti-ischemic effects of the potassium channel activators pinacidil and cromakalim and the reversal of these effects with the potassium channel blocker glyburide.
    Grover GJ; McCullough JR; Henry DE; Conder ML; Sleph PG
    J Pharmacol Exp Ther; 1989 Oct; 251(1):98-104. PubMed ID: 2507775
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Kinetics of bupivacaine after levcromakalim treatment in mice.
    Gantenbein M; Attolini L; Bruguerolle B
    J Pharm Pharmacol; 1997 Mar; 49(3):293-5. PubMed ID: 9231348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suppression of repolarization-related arrhythmias in vitro and in vivo by low-dose potassium channel activators.
    Fish FA; Prakash C; Roden DM
    Circulation; 1990 Oct; 82(4):1362-9. PubMed ID: 1698129
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative effects of the potassium channel openers cromakalim and pinacidil and the cromakalim analog U-89232 on isolated vascular and cardiac tissue.
    Norman NR; Toombs CF; Khan SA; Buchanan LV; Cimini MG; Gibson JK; Meisheri KD; Shebuski RJ
    Pharmacology; 1994 Aug; 49(2):86-95. PubMed ID: 7972325
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cromakalim, nicorandil and pinacidil: novel drugs which open potassium channels in smooth muscle.
    Hamilton TC; Weston AH
    Gen Pharmacol; 1989; 20(1):1-9. PubMed ID: 2523328
    [No Abstract]   [Full Text] [Related]  

  • 40. Regulation of ATP-sensitive K+ channels by ATP and nucleotide diphosphate in rabbit portal vein.
    Kamouchi M; Kitamura K
    Am J Physiol; 1994 May; 266(5 Pt 2):H1687-98. PubMed ID: 8203568
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.